JANSSEN BIOTECH, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1979-01-01
- Employees
- 10K
- Market Cap
- -
Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis
Completed
- Conditions
- Inflammatory Bowel Disease
- Interventions
- Other: No intervention
- First Posted Date
- 2008-04-15
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Janssen Biotech, Inc.
- Target Recruit Count
- 370
- Registration Number
- NCT00658827
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
Active, not recruiting
- Conditions
- Crohn's DiseaseUlcerative ColitisIndeterminate ColitisInflammatory Bowel Diseases
- Interventions
- Biological: Anti TNF therapy including infliximab
- First Posted Date
- 2008-02-01
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Janssen Biotech, Inc.
- Target Recruit Count
- 4970
- Registration Number
- NCT00606346
The Crohn's Therapy, Resource, Evaluation, and Assessment Tool Registry
Completed
- Conditions
- Crohn's Disease
- Interventions
- Other: No intervention
- First Posted Date
- 2007-11-04
- Last Posted Date
- 2013-03-04
- Lead Sponsor
- Janssen Biotech, Inc.
- Target Recruit Count
- 6273
- Registration Number
- NCT00553176